Christophe Sajous

8PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 31, 2025
From hyperplasia to carcinoma: a molecular driven adrenal disease.

Elisa Dybal, Myriam Decaussin-Petrucci, Françoise Descotes

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Apr 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud

|Jan 11, 2022
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).

Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas

Pageof 2